HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis and Antiproliferative Evaluation of 2-Deoxy-N-glycosylbenzotriazoles/imidazoles.

Abstract
A series of 2-deoxy-2-iodo-α-d-mannopyranosylbenzotriazoles was synthesized using the benzyl, 4,6-benzylidene and acetyl protected D-glucal in the presence of N-iodosuccinimide (NIS). Subsequent removal of the iodine at the C-2 position using tributyltin hydride under free radical conditions afforded the 2-deoxy-α-d-glucopyranosylbenzotriazoles in moderate to high yields. This method was extended to the preparation of substituted 2-deoxy-β-d-glucopyranosylimidazoles as well. The stereoselectivity of the addition reaction and the effect of the protecting group and temperature on anomer distribution of the benzotriazole series were also investigated. The anticancer properties of the newly synthesized compounds were evaluated in a series of viability studies using HeLa (human cervical adenocarcinoma), human breast and lung cancer cell lines. The N-[3,4,6-tri-O-benzyl-2-deoxy-α-d-glucopyranosyl]-1H-benzotriazole and the N-[3,4,6-tri-O-acetyl-2-deoxy-α-d-glucopyranosyl]-2H-benzotriazole were found to be the most potent cancer cell inhibitors at 20 µM concentrations across all four cell lines.
AuthorsCaleigh S Garton, Noelle K DeRose, Dylan Dominguez, Maria L Turbi-Henderson, Ashley L Lehr, Ashley D Padilla, Scott D Twining, Stephanie Casas, Chidozie O Alozie, Azad L Gucwa, Mohammed R Elshaer, Michael De Castro
JournalMolecules (Basel, Switzerland) (Molecules) Vol. 26 Issue 12 (Jun 19 2021) ISSN: 1420-3049 [Electronic] Switzerland
PMID34205324 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Imidazoles
  • Triazoles
  • benzotriazole
Topics
  • Antineoplastic Agents (chemical synthesis, pharmacology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • HeLa Cells
  • Humans
  • Imidazoles (chemical synthesis, pharmacology)
  • Neoplasms (drug therapy)
  • Temperature
  • Triazoles (chemical synthesis, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: